LVMH Moet Hennessy Louis Vuitton SA Given Buy Rating at AlphaValue (MC)

LVMH Moet Hennessy Louis Vuitton SA (EPA: MC)‘s stock had its “buy” rating reaffirmed by stock analysts at AlphaValue in a report issued on Thursday, AnalystRatings.Net reports. They currently have a €175.00 ($227.27) target price on the stock.

MC has been the subject of a number of other recent research reports. Analysts at Aurel – BGC reiterated a “buy” rating on shares of LVMH Moet Hennessy Louis Vuitton SA in a research note to investors on Tuesday. They now have a €150.00 ($194.81) price target on the stock. Finally, analysts at Sanford C. Bernstein reiterated an “outperform” rating on shares of LVMH Moet Hennessy Louis Vuitton SA in a research note to investors on Wednesday, May 29th.

Six analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of €151.51 ($196.77).

LVMH Moet Hennessy Louis Vuitton SA (EPA: MC) opened at 125.85 on Thursday. LVMH Moet Hennessy Louis Vuitton SA has a 52-week low of €113.55 and a 52-week high of €143.40. The stock’s 50-day moving average is currently €125.6. The company has a market cap of €62.924 billion and a price-to-earnings ratio of 18.48.

LVMH Moet Hennessy Louis Vuitton SA (EPA: MC) is a France-based luxury goods company.

Latest News

First Quantum Minerals Limited  Given Consensus Recommendation of “Buy” by Brokerages
First Quantum Minerals Limited Given Consensus Recommendation of “Buy” by Brokerages
Advanced Micro Devices, Inc.  Expected to Post Quarterly Sales of $1.45 Billion
Advanced Micro Devices, Inc. Expected to Post Quarterly Sales of $1.45 Billion
BT2 [CST]  Hits Market Cap of $0.00
BT2 [CST] Hits Market Cap of $0.00
Substratum Reaches 24 Hour Trading Volume of $120,476.00
Substratum Reaches 24 Hour Trading Volume of $120,476.00
Ryder System  Reaches New 52-Week Low at $49.59
Ryder System Reaches New 52-Week Low at $49.59
Insider Buying: Oncolytics Biotech, Inc.  Director Buys 5,000 Shares of Stock
Insider Buying: Oncolytics Biotech, Inc. Director Buys 5,000 Shares of Stock


© 2006-2018 Ticker Report